Autoimmunity as a Predisposition for Infectious Diseases
article has not abstract
Vyšlo v časopise:
Autoimmunity as a Predisposition for Infectious Diseases. PLoS Pathog 6(11): e32767. doi:10.1371/journal.ppat.1001077
Kategorie:
Opinion
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001077
Souhrn
article has not abstract
Zdroje
1. ShoenfeldY
1994 Idiotypic induction of autoimmunity: a new aspect of the idiotypic network. FASEB J 8 1296 1301
2. KivityS
Agmon-LevinN
BlankM
ShoenfeldY
2009 Infections and autoimmunity—friends or foes? Trends Immunol 30 409 414
3. Agmon-LevinN
PazZ
IsraeliE
ShoenfeldY
2009 Vaccines and autoimmunity. Nat Rev Rheumatol 5 648 652
4. InvernizziP
GershwinME
2009 The genetics of human autoimmune disease. J Autoimmun 33 290 299
5. HewagamaA
RichardsonB
2009 The genetics and epigenetics of autoimmune diseases. J Autoimmun 33 3 11
6. ZhuJ
PaulWE
2008 CD4 T cells: fates, functions, and faults. Blood 112 1557 1569
7. BettelliE
KornT
OukkaM
KuchrooVK
2008 Induction and effector functions of T(H)17 cells. Nature 453 1051 1057
8. DubinPJ
KollsJK
2008 Th17 cytokines and mucosal immunity. Immunol Rev 226 160 171
9. AimaniandaV
HaenslerJ
Lacroix-DesmazesS
KaveriSV
BayryJ
2009 Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. Trends Pharmacol Sci 30 287 295
10. DinarelloCA
2003 Anti-cytokine therapeutics and infections. Vaccine 21 Suppl 2 S24 34
11. WinthropKL
ChillerT
2009 Preventing and treating biologic-associated opportunistic infections. Nat Rev Rheumatol 5 405 410
12. Marodi L, Casanova JL Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies? Nat Rev Immunol 10 299 300
13. MadariagaL
AmurrioC
MartinG
Garcia-CebrianF
BicandiJ
1998 Detection of anti-interferon-γ autoantibodies in subjects infected by Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2 62 68
14. DoffingerR
HelbertMR
Barcenas-MoralesG
YangK
DupuisS
2004 Autoantibodies to interferon-γ in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 38 e10 14
15. HoflichC
SabatR
RosseauS
TemmesfeldB
SlevogtH
2004 Naturally occurring anti-IFN-γ autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 103 673 675
16. KampmannB
HemingwayC
StephensA
DavidsonR
GoodsallA
2005 Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-γ. J Clin Invest 115 2480 2488
17. PatelSY
DingL
BrownMR
LantzL
GayT
2005 Anti-IFN-γ autoantibodies in disseminated nontuberculous mycobacterial infections. J Immunol 175 4769 4776
18. TanakaY
HoriT
ItoK
FujitaT
IshikawaT
2007 Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-γ. Intern Med 46 1005 1009
19. KoyaT
TsubataC
KagamuH
KoyamaK
HayashiM
2009 Anti-interferon-γ autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother 15 118 122
20. BaerleckenN
JacobsR
StollM
SchmidtRE
WitteT
2009 Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-γ autoantibody. Clin Infect Dis 49 e76 78
21. CasanovaJL
AbelL
2002 Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 20 581 620
22. PuelA
PicardC
LorrotM
PonsC
ChrabiehM
2008 Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol 180 647 654
23. van der PollT
KeoghCV
GuiraoX
BuurmanWA
KopfM
1997 Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 176 439 444
24. van EnckevortFH
SweepCG
SpanPN
NeteaMG
HermusAR
2001 Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice. Eur Cytokine Netw 12 581 586
25. ColeN
BaoS
StapletonF
ThakurA
HusbandAJ
2003 Pseudomonas aeruginosa keratitis in IL-6-deficient mice. Int Arch Allergy Immunol 130 165 172
26. DiaoH
KohanawaM
2005 Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun 73 3745 3748
27. KitamuraT
TanakaN
WatanabeJ
Uchida, KanegasakiS
1999 Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 190 875 880
28. UchidaK
NakataK
SuzukiT
LuisettiM
WatanabeM
2009 Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood 113 2547 2556
29. UchidaK
BeckDC
YamamotoT
BerclazPY
AbeS
2007 GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 356 567 579
30. UchidaK
NakataK
TrapnellBC
TerakawaT
HamanoE
2004 High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 103 1089 1098
31. NakataK
KanazawaH
WatanabeM
2006 Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung? Respirology 11 Suppl S65 69
32. SakagamiT
UchidaK
SuzukiT
CareyBC
WoodRE
2009 Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med 361 2679 2681
33. SuzukiT
SakagamiT
RubinBK
NogeeLM
WoodRE
2008 Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med 205 2703 2710
34. ContiHR
ShenF
NayyarN
StocumE
SunJN
2009 Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206 299 311
35. LinL
IbrahimAS
XuX
FarberJM
AvanesianV
2009 Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 5 e1000703 doi:10.1371/journal.ppat.1000703
36. KisandK
Boe WolffAS
PodkrajsekKT
TserelL
LinkM
2010 Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 207 299 308
37. PuelA
DoffingerR
NatividadA
ChrabiehM
Barcenas-MoralesG
2010 Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207 291 297
38. de BeaucoudreyL
PuelA
Filipe-SantosO
CobatA
GhandilP
2008 Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 205 1543 1550
39. MeagerA
WadhwaM
DilgerP
BirdC
ThorpeR
2003 Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-α, interferon-ω and interleukin-12 in patients with thymoma and/or myasthenia gravis. Clin Exp Immunol 132 128 136
40. ZhangW
LiuJL
MeagerA
Newsom-DavisJ
WillcoxN
2003 Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-γ responses of healthy CD4+ T cells. J Neuroimmunol 139 102 108
41. van de VosseE
van DisselJT
OttenhoffTH
2009 Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 9 688 698
42. FerwerdaB
FerwerdaG
PlantingaTS
WillmentJA
van SprielAB
2009 Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361 1760 1767
43. GlockerEO
HennigsA
NabaviM
SchafferAA
WoellnerC
2009 A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361 1727 1735
44. CawsM
ThwaitesG
DunstanS
HawnTR
LanNT
2008 The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 4 e1000034 doi:10.1371/journal.ppat.1000034
45. MeagerA
VisvalingamK
PetersonP
MollK
MurumagiA
2006 Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3 e289 doi:10.1371/journal.pmed.0030289
46. EdwardsJC
CambridgeG
2006 B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6 394 403
47. TedderTF
2009 CD19: a promising B cell target for rheumatoid arthritis. Nat Rev Rheumatol 5 572 577
48. DornerT
RadbruchA
BurmesterGR
2009 B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol 5 433 441
49. KorhonenR
MoilanenE
2009 Anti-CD20 antibody rituximab in the treatment of rheumatoid arthritis. Basic Clin Pharmacol Toxicol 106 13 21
50. McDonaldV
LeandroM
2009 Rituximab in non-haematological disorders of adults and its mode of action. Br J Haematol 146 233 246
51. KazatchkineMD
KaveriSV
2001 Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345 747 755
52. Tha-InT
BayryJ
MetselaarHJ
KaveriSV
KwekkeboomJ
2008 Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol 29 608 615
53. BayryJ
Lacroix-DesmazesS
KazatchkineMD
KaveriSV
2004 Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? Trends Pharmacol Sci 25 306 310
54. AhmedAR
SpigelmanZ
CavaciniLA
PosnerMR
2006 Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. N Engl J Med 355 1772 1779
55. VoAA
LukovskyM
ToyodaM
WangJ
ReinsmoenNL
2008 Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359 242 251
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 11
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Zn Inhibits Coronavirus and Arterivirus RNA Polymerase Activity and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
- The Female Lower Genital Tract Is a Privileged Compartment with IL-10 Producing Dendritic Cells and Poor Th1 Immunity following Infection
- Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41
- The Arabidopsis Resistance-Like Gene Is Activated by Mutations in and Contributes to Resistance to the Bacterial Effector AvrRps4